Home/Filings/4/0001225208-18-015063
4//SEC Filing

Scholefield James H 4

Accession 0001225208-18-015063

CIK 0000310158other

Filed

Oct 31, 8:00 PM ET

Accepted

Nov 1, 5:03 PM ET

Size

7.6 KB

Accession

0001225208-18-015063

Insider Transaction Report

Form 4
Period: 2018-10-30
Scholefield James H
EVP,Chief Info&Digital Officer
Transactions
  • Award

    Stock Option (right to buy)

    2018-10-30+47,45647,456 total
    Exercise: $72.87From: 2019-10-30Exp: 2028-10-29Common Stock (47,456 underlying)
  • Award

    Restricted Stock Unit

    2018-10-30+34,30834,308 total
    From: 2019-10-30Exp: 2021-10-30Common Stock (34,308 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
  • [F2]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021.
  • [F3]The option vests and becomes exercisable in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021.

Documents

1 file

Issuer

Merck & Co., Inc.

CIK 0000310158

Entity typeother

Related Parties

1
  • filerCIK 0001720922

Filing Metadata

Form type
4
Filed
Oct 31, 8:00 PM ET
Accepted
Nov 1, 5:03 PM ET
Size
7.6 KB